CLINICAL_TRIALS
trial_result
· 2017-02-10
Clinical Trial Update: Safety, Tolerability and PK of Imeglimin in Japanese Volunteers [Phase 1]
Summary
Phase 1 study assessing safety, tolerability, and pharmacokinetics of imeglimin in Japanese volunteers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Poxel SA | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED